Doorgaan naar hoofdnavigatie
Doorgaan naar zoeken
Ga verder naar hoofdinhoud
Sorteer per
Medicine and Dentistry
Ganglioneuroblastoma
100%
Liquid Biopsy
57%
Cell-Free DNA
46%
Minimal Residual Disease
45%
Messenger RNA
43%
Pediatrics
38%
Neoplasm
37%
Droplet Digital Polymerase Chain Reaction
30%
Biological Marker
27%
Pediatric Cancer
27%
Solid Malignant Neoplasm
24%
Immunotherapy
24%
Rhabdomyosarcoma
22%
Patient with Neuroblastoma
20%
Quantitative Reverse Transcription Polymerase Chain Reaction
14%
Sensitive Detection
14%
Organoid
14%
Metastatic Carcinoma
14%
Event Free Survival
13%
Diseases
13%
Neuroblastoma Cell
12%
Pontine Glioma
12%
Germinoma
12%
Circulating Tumor DNA
12%
DNA Marker
12%
Genetic Marker
12%
Overall Survival
9%
Tumor Marker
8%
Tumor
8%
Size-Exclusion Chromatography
8%
Wilms' Tumor
8%
Reverse Transcriptase
8%
Fusion Gene
7%
Ewing Sarcoma
6%
Hazard Ratio
6%
Whole Genome Sequencing
6%
Biopsy Technique
6%
Reduced Representation Bisulfite Sequencing
6%
CHRNA3
5%
Ex Vivo
5%
Intracranial Tumor
5%
Keyphrases
Neuroblastoma
40%
Minimal Residual Disease
26%
Cell-free DNA (cfDNA)
24%
RASSF1A
24%
Liquid Biopsy
24%
Pediatric Tumors
24%
Bone Marrow
21%
Droplet Digital PCR (ddPCR)
18%
Peripheral Blood
18%
High-risk Neuroblastoma
16%
Quantitative PCR
15%
Working Diagnosis
14%
RNA Markers
13%
Neuroblastoma Cells
12%
Marker Panel
12%
Pediatric Rhabdomyosarcoma
12%
Targeted Locus Amplification
12%
Diagnostic Biomarker
12%
Prognostic Biomarker
12%
Patient-specific
12%
Validation Studies
12%
Bone Marrow Niche
12%
Mesenchymal Stromal Cells
12%
Metastatic Bone
12%
Organoid Co-culture
12%
Personalized Assessment
12%
Routinely Collected
12%
Event-free Survival
12%
Rhabdomyosarcoma
11%
During Treatment
10%
Tumor-derived
10%
Overall Survival
9%
Plasma Samples
7%
Fusion Gene
7%
Specific Marker
7%
Peripheral Blood Samples
7%
Poor Outcome
6%
Patient Samples
6%
Recurrent Disease
6%
PRRX1
6%
Mesenchymal Cells
6%
FMO3
6%
Cell Samples
6%
Peripheral Blood Stem Cells
6%
RNA Panel
5%
Infiltration
5%
Metastatic Neuroblastoma
5%
